Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
German American Bancorp
GABC
$1.91B
| $12.5M | ﹤0.01% |
349,669
+17,445
| +5% | +$583K |
|
|
LBAI
1852
DELISTED
Lakeland Bancorp Inc
LBAI
| $12.4M | ﹤0.01% |
715,787
+16,741
| +2% | +$276K |
|
|
NXRT
1853
NexPoint Residential Trust
NXRT
$631M
| $12.4M | ﹤0.01% |
276,083
+11,400
| +4% | +$537K |
|
1854
Caleres
CAL
$455M
| $12.4M | ﹤0.01% |
522,395
-10,513
| -2% | -$238K |
|
|
ACHN
1855
DELISTED
Achillion Pharmaceuticals
ACHN
| $12.4M | ﹤0.01% |
2,056,778
+43,085
| +2% | +$249K |
|
|
TVTY
1856
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $12.4M | ﹤0.01% |
609,012
+16,703
| +3% | +$313K |
|
|
IMGN
1857
DELISTED
Immunogen Inc
IMGN
| $12.4M | ﹤0.01% |
2,420,015
+99,317
| +4% | +$337K |
|
1858
Autohome
ATHM
$2.65B
| $12.3M | ﹤0.01% |
155,337
+8,292
| +6% | +$646K |
|
|
CISN
1859
DELISTED
Cision Ltd. Ordinary Share
CISN
| $12.3M | ﹤0.01% |
1,236,566
+143,919
| +13% | +$1.37M |
|
|
MAXR
1860
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $12.3M | ﹤0.01% |
785,524
+37,315
| +5% | +$388K |
|
1861
Federal Agricultural Mortgage
AGM
$2.58B
| $12.3M | ﹤0.01% |
147,344
+3,595
| +3% | +$299K |
|
1862
Acco Brands
ACCO
$399M
| $12.2M | ﹤0.01% |
1,306,931
+24,268
| +2% | +$230K |
|
|
FOCS
1863
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $12.2M | ﹤0.01% |
414,679
+20,987
| +5% | +$537K |
|
1864
TG Therapeutics
TGTX
$7.58B
| $12.2M | ﹤0.01% |
1,100,803
-14,542
| -1% | -$111K |
|
1865
Triumph Financial Inc
TFIN
$1.83B
| $12.2M | ﹤0.01% |
320,308
-3,568
| -1% | -$123K |
|
1866
BridgeBio Pharma
BBIO
$16.4B
| $12.2M | ﹤0.01% |
347,378
+11,930
| +4% | +$331K |
|
|
TRST
1867
Trustco Bank Corp NY
TRST
$963M
| $12.2M | ﹤0.01% |
280,644
+12,883
| +5% | +$551K |
|
|
ATNX
1868
DELISTED
Athenex, Inc. Common Stock
ATNX
| $12.1M | ﹤0.01% |
39,743
+2,312
| +6% | +$611K |
|
|
VNE
1869
DELISTED
Veoneer, Inc.
VNE
| $12.1M | ﹤0.01% |
775,612
+31,652
| +4% | +$510K |
|
1870
Atara Biotherapeutics
ATRA
$83.1M
| $12.1M | ﹤0.01% |
29,338
+1,478
| +5% | +$510K |
|
1871
Extreme Networks
EXTR
$3.2B
| $12.1M | ﹤0.01% |
1,636,055
-161,408
| -9% | -$1.13M |
|
|
CCF
1872
DELISTED
Chase Corporation
CCF
| $12.1M | ﹤0.01% |
101,759
+1,986
| +2% | +$230K |
|
|
MTSC
1873
DELISTED
MTS Systems Corp
MTSC
| $12.1M | ﹤0.01% |
251,014
+9,812
| +4% | +$521K |
|
1874
GSK
GSK
$101B
| $12.1M | ﹤0.01% |
205,202
+64,041
| +45% | +$3.56M |
|
1875
Designer Brands
DBI
$311M
| $12M | ﹤0.01% |
762,134
-22,898
| -3% | -$379K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.